George Morris Center to Disband, Transfer Assets Back to U of G

Jun 20, 2014

Canada’s only independent agricultural think-tank, the George Morris Centre (GMC), based in Guelph, Ont., announced that it will be moving to dissolve the organization within the year, and transfer its net assets as a gift to the Ontario Agricultural College (OAC), which is part of the University of Guelph.

Prior to 1998, GMC operated as a stand-alone unit at the University of Guelph for about 10 years. The centre began with the late George Fletcher Morris, a beef and cash crop farmer from Merlin, Ontario. Morris was a highly respected leader in the agricultural industry. He played a pivotal role in working with the University of Guelph to create an organization that would focus on supporting agriculture policy analyses and research.

The 15-year think-tank encouraged research and policy discussion on agri-food issues. GMC would regularly publish research and market reports. Its research focused primarily on five key research areas: agribusiness intelligence, economics of agri-food policy, economics of food, health and sustainability, market analysis and value chain management.

"We are proud of the reputation and the provocative discussion that has been created over the years by a succession of dedicated GMC team members,” Bob Funk, board chair of GMC said in a release.

GMC operated under the direction of a board of directors (nine members) from across the country, representing the provinces of Ontario, Alberta, Saskatchewan and Manitoba.

According to GMC, a transition team is in place to oversee the changeover back to the OAC at the University of Guelph.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.